24 Hours to Save AIDS Research
On September 16 at 11 am (U.S.) savesaidsresearch.org starts a massive marathon to save AIDS funding.
Treatment Action Group Statement on Suspension of TB Funding Over White House Gain-of-Function Fictions
Treatment Action Group (TAG) opposes in the strongest possible terms the suspension of at least 22 TB research awards by the National Institutes of Health (NIH) following a May 2025 White House executive order banning “gain-of-function” research.
Story: HIV cure “breakthrough” with mRNA-delivered Tat protein
June 2025 Media coverage: Breakthrough in search for HIV cure leaves researchers ‘overwhelmed’ - Kat Lay, The Guardian, June 5, 2025 Major breakthrough in battle for HIV cure ‘previously thought impossible’ - Athena Stavrou, Independent, June 5, 2025 Used in…
Treatment Action Group Statement on Termination of HIV Vaccine Research Funding
On Friday May 30, it was reported that National Institutes of Health (NIH) leadership has unilaterally terminated funding for HIV vaccine research consortia that were making significant progress toward solving the stern challenge of inducing protective broadly neutralizing antibodies against the virus.
Tuberculosis Research at the National Institutes of Health – Saving Lives, Shrinking Costs, Fueling American Jobs and Innovation
This policy brief describes the crucial role NIH plays in supporting research on new products to prevent, diagnose, and cure TB. This research is especially important at a time when new forms of drug resistance are emerging globally, and rates of TB are rising in the U.S. With continued and increased funding, NIH can protect Americans from the growing threat of TB at home and abroad.
HIV Cure Research Information Sheet
Research into curing HIV infection is ever-changing as new discoveries are made and scientists report additional rare — but informative — cases of individuals likely cured of HIV.
2025 Pre-CROI Community HIV Cure Research Workshop
The 2025 Pre-CROI Community HIV Cure Research Workshop will take place on Saturday, March 8 in San Francisco.
Community Surveys Show Enthusiasm for Long-Acting HCV Cure Research
People living with or at risk of hepatitis C Virus (HCV), health care providers, and policymakers in low- and middle-income countries (LMICs) showed significant interest in a potential long-acting HCV cure, recent surveys have found.
2024 Report on TB Research Funding Trends
A new report released today by Treatment Action Group (TAG) and Stop TB Partnership found that cumulative funding for tuberculosis (TB) research and development (R&D) in 2023 reached only 24% of the annual $5 billion funding target agreed by countries at the United Nations High-Level Meeting (HLM) on TB in September 2023.
TB R&D Funding: Billions Short and Reliant on a Few Major Donors, New Report Finds
A new report released today by Treatment Action Group (TAG) and Stop TB Partnership found that cumulative funding for tuberculosis (TB) research and development (R&D) in 2023 reached only 24% of the annual $5 billion funding target agreed by countries at the United Nations High-Level Meeting (HLM) on TB in September 2023.